XML 26 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CASH EQUIVALENTS AND INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2019
Investments, All Other Investments [Abstract]  
Schedule of amortized cost, gross unrealized gains and losses and fair value of marketable debt and equity securities and investments
The amortized cost, gross unrealized gains and losses and fair value of the Company's cash equivalents and marketable securities at December 31, 2018 were comprised of the following (in thousands):
 
 
 
 
 
 
 
 
 
December 31, 2018
 
Amortized
cost
 
Unrealized
gains
 
Unrealized
losses
 
Fair
value
Cash equivalents
$
310

 
$

 
$

 
$
310

 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
U.S. government agency notes
$
3,998

 
$

 
$
(9
)
 
$
3,989

Corporate debt securities
3,301

 

 
(6
)
 
3,295

 
$
7,299

 
$

 
$
(15
)
 
$
7,284


Schedule of fair value of financial assets
The following table shows the fair value of the Company's financial assets at December 31, 2018. These financial assets are comprised of the Company's available-for-sale debt securities and reported under the captions Cash and cash equivalents and Marketable securities in the consolidated balance sheets (in thousands):
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements at
December 31, 2018 using:
 
Total carrying
value at
December 31,
2018
 
Quoted prices
in active
markets
(Level 1)
 
Significant other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Cash equivalents
$
310

 
$
310

 
$

 
$

 
 
 
 
 
 
 
 
Marketable securities
 
 
 
 
 
 
 
U.S. government agency notes
$
3,989

 
$

 
$
3,989

 
$

Corporate debt securities
3,295

 

 
3,295

 

 
$
7,284

 
$

 
$
7,284

 
$